An ADI value is based on current research, with long-term studies on animals and observations of humans. First, a no-observed-adverse-effect level (NOAEL), the amount of a substance that shows no toxic effects, is determined. Usually the studies are performed with several doses including high doses. In the case of several studies on different effects, the lowest NOAEL is usually taken.  Then, the NOAEL (or another point of departure such as a benchmark dose level (BMDL)) is divided by a safety factor, conventionally 100, to account for the differences between test animals and humans (factor of 10) and possible differences in sensitivity between humans (another factor of 10). safety factors with values other than 100 may be used if information on uncertainty about the value of the point of departure (NOAEL or BMDL) justify it. For instance, if the ADI is based on data from humans the safety factor is usually 10 instead of 100. The ADI is usually given in mg per kg body weight.The ADI is considered a safe intake level for a healthy adult of normal weight who consumes an average daily amount of the substance in question. Increased safety factors for infants have been discussed, but are not needed, because elimination of chemicals is in fact often more rapid in children and as children generally suffer higher illness rates than adults, adverse effects caused by food additives can easily be disguised as any number of things children usually suffer with. It would be far more difficult to argue the case with a healthy adult. The ADI does not take into account allergic reactions that are individual responses rather than dose-dependent phenomena.
An ADI value is based on current research, with long-term studies on animals and observations of humans. First, a no-observed-adverse-effect level (NOAEL), the amount of a substance that shows no toxic effects, is determined. Usually the studies are performed with several doses including high doses. In the case of several studies on different effects, the lowest NOAEL is usually taken.  Then, the NOAEL (or another point of departure such as a benchmark dose level (BMDL)) is divided by a safety factor, conventionally 100, to account for the differences between test animals and humans (factor of 10) and possible differences in sensitivity between humans (another factor of 10). safety factors with values other than 100 may be used if information on uncertainty about the value of the point of departure (NOAEL or BMDL) justify it. For instance, if the ADI is based on data from humans the safety factor is usually 10 instead of 100. The ADI is usually given in mg per kg body weight.The ADI is considered a safe intake level for a healthy adult of normal weight who consumes an average daily amount of the substance in question. Increased safety factors for infants have been discussed, but are not needed, because elimination of chemicals is in fact often more rapid in children and as children generally suffer higher illness rates than adults, adverse effects caused by food additives can easily be disguised as any number of things children usually suffer with. It would be far more difficult to argue the case with a healthy adult. The ADI does not take into account allergic reactions that are individual responses rather than dose-dependent phenomena.
在這些實驗中，大約使用多少個不同的劑量？
資訊抽取
問答